MCE - Delayed Quote EUR

Clínica Baviera, S.A. (CBAV.MC)

38.40
-0.30
(-0.78%)
At close: May 23 at 5:35:07 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
262,648
262,648
224,923.95
198,449.25
172,730.25
Cost of Revenue
30,565
30,565
27,073.99
25,501.56
21,484.42
Gross Profit
232,083
232,083
197,849.97
172,947.69
151,245.83
Operating Expense
176,436
176,436
147,809.28
130,832.48
111,783.58
Operating Income
55,647
55,647
50,040.69
42,115.22
39,462.25
Net Non Operating Interest Income Expense
-921
-921
-420.31
-351.62
-455.11
Pretax Income
55,991
55,991
49,653.04
40,679.93
38,899.36
Tax Provision
14,855
14,855
12,918.70
10,533.13
10,967.86
Net Income Common Stockholders
40,205
40,205
35,970.93
29,518.53
27,389.53
Diluted NI Available to Com Stockholders
40,205
40,205
35,970.93
29,518.53
27,389.53
Basic EPS
2.47
2.47
2.21
1.81
1.68
Diluted EPS
2.47
2.47
2.21
1.81
1.68
Basic Average Shares
16,277.33
16,277.33
16,276.47
16,303.01
16,303.01
Diluted Average Shares
16,277.33
16,277.33
16,276.47
16,303.01
16,303.01
Total Operating Income as Reported
55,674
55,674
50,014.02
41,492.47
39,429.18
Rent Expense Supplemental
--
--
1,778.10
1,824.12
1,449.21
Total Expenses
207,001
207,001
174,883.26
156,334.04
133,268
Net Income from Continuing & Discontinued Operation
40,205
40,205
35,970.93
29,518.53
27,389.53
Normalized Income
39,289.58
39,289.58
35,941.40
30,163.97
27,441.71
Interest Income
296
296
151.34
67.21
3.19
Interest Expense
1,217
1,217
571.65
418.83
458.30
Net Interest Income
-921
-921
-420.31
-351.62
-455.11
EBIT
57,208
57,208
50,224.69
41,098.77
39,357.66
EBITDA
78,088
78,088
67,205.23
56,095.88
53,451.55
Reconciled Cost of Revenue
30,565
30,565
27,073.99
25,501.56
21,484.42
Reconciled Depreciation
20,880
20,880
16,980.54
14,997.11
14,093.89
Net Income from Continuing Operation Net Minority Interest
40,205
40,205
35,970.93
29,518.53
27,389.53
Total Unusual Items Excluding Goodwill
1,246
1,246
39.91
-870.95
-72.67
Total Unusual Items
1,246
1,246
39.91
-870.95
-72.67
Normalized EBITDA
76,842
76,842
67,165.32
56,966.83
53,524.23
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
330.58
330.58
10.38
-225.51
-20.49
12/31/2021 - 4/3/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ERF.PA Eurofins Scientific SE
56.40
-0.18%
 
PANG.MC Pangaea Oncology, S.A.
1.7300
0.00%
 
PKN.MU PerkinElmer Inc
79.70
0.00%
 
ESF0.MU Eurofins Scientific SE
56.60
+0.28%
 
MTO.F Mettler-Toledo International Inc.
996.40
-0.10%
 
INIFY.OL INIFY Laboratories AB
7.25
-0.68%
 
DSRLF DiaSorin S.p.A.
104.69
0.00%
 
ABDX.L Abingdon Health Plc
6.25
0.00%
 
VOX.WA Voxel S.A.
154.00
-0.65%
 
DIA.WA Diagnostyka S.A.
169.05
-1.20%